BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 18576213)

  • 1. Neurofibromatosis type 1 association with moyamoya disease.
    Koc F; Yerdelen D; Koc Z
    Int J Neurosci; 2008 Aug; 118(8):1157-63. PubMed ID: 18576213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Moya' than meets the eye: neurofibromatosis type 1 associated with Moyamoya syndrome.
    Tan RM; Chng SM; Seow WT; Wong J; Lim CC
    Singapore Med J; 2008 Apr; 49(4):e107-9. PubMed ID: 18418511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofibromatosis type 1 associated with Charcot-Marie-Tooth type 1A.
    Koc F; Guzel AI
    J Dermatol; 2009 May; 36(5):306-11. PubMed ID: 19383003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1.
    Rosser TL; Vezina G; Packer RJ
    Neurology; 2005 Feb; 64(3):553-5. PubMed ID: 15699396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recklinghausen neurofibromatosis. Report of a case].
    Tripi TR; Bonaccorso A
    Minerva Stomatol; 1998 Nov; 47(11):617-22. PubMed ID: 9882998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perfusion MRI abnormalities in the absence of diffusion changes in a case of moyamoya-like syndrome in neurofibromatosis type 1.
    El-Koussy M; Lövblad KO; Steinlin M; Kiefer C; Schroth G
    Neuroradiology; 2002 Nov; 44(11):938-41. PubMed ID: 12428131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moyamoya syndrome associated with neurofibromatosis type 1 in a pediatric patient.
    Serafini NB; Serafini CB; Vinhas AS; Godinho MB
    An Bras Dermatol; 2017; 92(6):870-873. PubMed ID: 29364453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurofibromatosis type 1 associated with moyamoya syndrome. Case report and review of the literature.
    Budişteanu M; Burloiu CM; Papuc SM; Focşa IO; Riga D; Riga S; Arghir A
    Rom J Morphol Embryol; 2019; 60(2):713-716. PubMed ID: 31658349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case of moyamoya disease in a patient with advanced acquired immunodeficiency syndrome.
    Sharfstein SR; Ahmed S; Islam MQ; Najjar MI; Ratushny V
    J Stroke Cerebrovasc Dis; 2007; 16(6):268-72. PubMed ID: 18035245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moyamoya syndrome and neurofibromatosis type 1.
    Vargiami E; Sapountzi E; Samakovitis D; Batzios S; Kyriazi M; Anastasiou A; Zafeiriou DI
    Ital J Pediatr; 2014 Jun; 40():59. PubMed ID: 24952383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral hemodynamics and oxygen metabolism in patients with moyamoya syndrome associated with atherosclerotic steno-occlusive arterial lesions.
    Kato H; Shimosegawa E; Oku N; Kimura Y; Kajimoto K; Tanaka M; Hori M; Kitagawa K; Hatazawa J
    Cerebrovasc Dis; 2008; 26(1):9-15. PubMed ID: 18511866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult-Onset Hemorrhagic Quasi-Moyamoya Disease with Unilateral Steno-occlusive Lesion in a Patient with Neurofibromatosis Type 1.
    Hori YS; Ebisudani Y; Aoi M; Fukuhara T
    J Stroke Cerebrovasc Dis; 2018 May; 27(5):1423-1424. PubMed ID: 29305273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe cerebral vaso-occlusive disease in macrophage activation syndrome.
    El-Bitar MK; Muwakkit SA; Hourani R; Abboud MR; Saab R; Dabbagh O
    Pediatr Neurol; 2010 Apr; 42(4):283-6. PubMed ID: 20304334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofibromatosis type 1 associated with moyamoya syndrome in children.
    Duat-Rodríguez A; Carceller Lechón F; López Pino MÁ; Rodríguez Fernández C; González-Gutiérrez-Solana L
    Pediatr Neurol; 2014 Jan; 50(1):96-8. PubMed ID: 24269170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moyamoya disease in a child with neurofibromatosis type-1.
    Kwong KL; Wong YC
    J Paediatr Child Health; 1999 Feb; 35(1):108-9. PubMed ID: 10234650
    [No Abstract]   [Full Text] [Related]  

  • 16. [von Recklinghausen's disease associated with occlusion of bilateral middle cerebral artery, moyamoya phenomenon, and anterior communicating artery aneurysm. Report of an autopsy case].
    Chono Y; Ueno K; Nunomura M; Ohta Y; Nomura M; Nakamura N
    Neurol Med Chir (Tokyo); 1985 Mar; 25(3):209-14. PubMed ID: 2409466
    [No Abstract]   [Full Text] [Related]  

  • 17. Segmental neurofibromatosis type 1 (NF1) associated with Cobb syndrome: case report.
    Pascual-Castroviejo I; Pascual-Pascual SI; Viaño J
    Neuropediatrics; 2008 Dec; 39(6):341-3. PubMed ID: 19568998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pleomorphic xanthoastrocytoma and moyamoya disease in a patient with neurofibromatosis type 1 - case report - .
    Horiguchi S; Mitsuya K; Watanabe R; Yagishita S; Nakasu Y
    Neurol Med Chir (Tokyo); 2011; 51(4):310-4. PubMed ID: 21515957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moyamoya disease--magnetic resonance imaging and magnetic resonance angiographic features.
    Gupta R; Kumari R; Gupta N; Prakash A; Chowdhury V
    J Indian Med Assoc; 2006 Apr; 104(4):198-9. PubMed ID: 16910328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple intracranial arterial occlusions (moyamoya disease) in patients with neurofibromatosis. One case report with autopsy.
    Lamas E; Diez Lobato R; Cabello A; Abad JM
    Acta Neurochir (Wien); 1978; 45(1-2):133-45. PubMed ID: 105565
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.